DNA Aptamer-Functionalized Fluorescent Silica Nanoparticles: A Robust Strategy for Specific Detection and Bioimaging of HER2-Overexpressing Breast Cancer
International Journal of Nanomedicine · 2026-03 · Volume 21 · 1-16
DOI: 10.2147/ijn.s591943 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-03. Verfasst von Juntao Tan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital, Nanchang People's Hospital Affiliated of Nanchang Medical College, Na…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Silicon Dioxide, Breast Neoplasms, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Precise detection of HER2-positive breast cancer is vital for targeted therapy. This study integrates HER2-specific DNA aptamers with fluorescent silica nanoparticles (FSNPs) to develop a targeted imaging probe.
Methods
HER2 aptamer-conjugated FSNPs (HApt-FSNPs) were synthesized and characterized. Specificity was evaluated in HER2-positive/negative cells and tumor sections via flow cytometry and microscopy. Targeting efficacy and biodistribution were assessed in tumor-bearing mice through systemic injection and real-time fluorescence imaging. Photostability and biosafety were systematically examined.
Results
HApt-FSNPs showed uniform size, excellent dispersity, and enhanced photostability. They selectively bound HER2-positive cells and tumor tissues, with binding effectively blocked by free aptamer. In vivo imaging revealed specific accumulation in HER2-positive tumors, peaking at 6 hours post-injection, with minimal off-target signals. The probe demonstrated good biocompatibility in vitro and in vivo.
Conclusion
The HApt-FSNP platform enables specific detection and in vivo imaging of HER2-positive breast cancer, highlighting its potential for diagnostic and bioimaging applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Province Key Laboratory of Breast Diseases, Nanchang People's Hospital, Nanchang People's Hospital Affiliated of Nanchang Medical College, Nanchang, Jiangxi, People's Republic of China.
- Clinical Laboratory Center, The First affiliated hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region, People's Republic of China.
- Department of Pathology, Nanchang People's Hospital, Nanchang People's Hospital Affiliated of Nanchang Medical College, Nanchang, Jiangxi, People's Republic of China.
- Department of Breast Surgery, Nanchang People's Hospital, Nanchang People's Hospital Affiliated of Nanchang Medical College, Nanchang, Jiangxi, People's Republic of China.
Zitieren
APA
Tan, J., Hu, Z., Huang, D., Cheng, S., Chen, L., Min, L., Tu, J., & Li, Z. (2026). DNA Aptamer-Functionalized Fluorescent Silica Nanoparticles: A Robust Strategy for Specific Detection and Bioimaging of HER2-Overexpressing Breast Cancer. International Journal of Nanomedicine, Volume 21, 1-16. https://doi.org/10.2147/ijn.s591943
Vancouver
Tan J, Hu Z, Huang D, Cheng S, Chen L, Min L, et al. DNA Aptamer-Functionalized Fluorescent Silica Nanoparticles: A Robust Strategy for Specific Detection and Bioimaging of HER2-Overexpressing Breast Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-16. doi:10.2147/ijn.s591943
BibTeX
@article{Tan2026,
author = {Tan, Juntao and Hu, Zixi and Huang, Da and Cheng, Suqing and Chen, Lu and Min, Liangliang and Tu, Jianhong and Li, Zhihua},
title = {DNA Aptamer-Functionalized Fluorescent Silica Nanoparticles: A Robust Strategy for Specific Detection and Bioimaging of HER2-Overexpressing Breast Cancer},
journal = {International Journal of Nanomedicine},
year = {2026},
volume = {Volume 21},
pages = {1--16},
doi = {10.2147/ijn.s591943}
}
EUVIMED